phenyl acetate has been researched along with Glaucoma, Suspect in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, L; Bogner, B; Bruckner, D; Brunner, SM; Kaser-Eichberger, A; Koller, A; Ladek, AM; Motloch, K; Preishuber-Pfluegl, J; Reitsamer, HA; Runge, C; Schroedl, F; Strohmaier, C; Trost, A | 1 |
| Ebner, M; Hurst, J; Januschowski, K; Mariacher, S; Schnichels, S; Spitzer, MS; Szurman, P | 1 |
| Brodie, FL; Brucker, AJ; Ghodasra, DH; Hui, JZ; Ruggiero, J; VanderBeek, BL | 1 |
| Courtney, R; Raber, S; Schachar, RA; Zhang, M | 1 |
| Benetz, BA; Howell, SJ; Lass, JH; Raber, S; Schachar, RA; Szczotka-Flynn, LB; Thomas, KV; Zhang, M | 1 |
2 trial(s) available for phenyl acetate and Glaucoma, Suspect
| Article | Year |
|---|---|
A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Receptors, Prostaglandin E, EP2 Subtype; Sulfonamides; Treatment Outcome | 2011 |
Subclinical increased anterior stromal reflectivity with topical taprenepag isopropyl.
Topics: Acetates; Administration, Topical; Aged; Aged, 80 and over; Cell Count; Corneal Diseases; Corneal Keratocytes; Corneal Pachymetry; Corneal Stroma; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Endothelium, Corneal; Epithelium, Corneal; Glaucoma, Open-Angle; Humans; Latanoprost; Microscopy, Confocal; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Receptors, Prostaglandin E, EP2 Subtype; Refraction, Ocular; Sulfonamides; Visual Acuity | 2013 |
3 other study(ies) available for phenyl acetate and Glaucoma, Suspect
| Article | Year |
|---|---|
Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Topics: Acetates; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Calcium-Binding Proteins; Cell Survival; Cyclopropanes; Disease Models, Animal; Electroretinography; Female; Gene Expression Regulation; Intraocular Pressure; Leukotriene Antagonists; Microfilament Proteins; Microglia; Microscopy, Confocal; Microscopy, Fluorescence; Ocular Hypertension; Quinolines; Rats; Rats, Inbred BN; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Retina; Retinal Ganglion Cells; RNA, Messenger; Sulfides; Tonometry, Ocular; Transcription Factor Brn-3B | 2021 |
Characterization of a Standardized Ex-vivo Porcine Model to Assess Short Term Intraocular Pressure Changes and Trabecular Meshwork Vitality After Pars Plana Vitrectomy with Different Silicone Oil and BSS Tamponades.
Topics: Acetates; Animals; Disease Models, Animal; Drug Combinations; Endotamponade; Equipment Design; Follow-Up Studies; In Situ Nick-End Labeling; Intraocular Pressure; Minerals; Ocular Hypertension; Postoperative Complications; Postoperative Period; Retinal Detachment; Silicone Oils; Sodium Chloride; Swine; Time Factors; Tonometry, Ocular; Trabecular Meshwork; Vitrectomy | 2017 |
Volume and composition of reflux after intravitreal injection.
Topics: Acetates; Aged; Aged, 80 and over; Biological Availability; Coloring Agents; Drug Combinations; Hematoxylin; Humans; Intraocular Pressure; Intravitreal Injections; Middle Aged; Minerals; Ocular Hypertension; Sodium Chloride; Tonometry, Ocular; Vitreous Body | 2014 |